An experimental stem cell therapy can essentially cure type 1 diabetes by restoring insulin production in some patients, early clinical trial results show. Seven out of 12 patients no longer needed daily insulin shots after receiving a full dose of the gene therapy, dubbed VX-800, researchers reported Friday at the American Diabetes Association’s annual meeting in Orlando, FL. Another two needed about 70% less insulin daily to keep their blood sugar stable, results show. “This positive data adds to the growing body of evidence for VX-880’s potential to revolutionize the Read More